Novartis Institutes for BioMedical Research (NIBR)
The Novartis Institutes for BioMedical Research is the innovation engine of Novartis. With approximately 6,000 scientists and physicians at NIBR around the world, our research is focused on discovering innovative new drugs that will change the practice of medicine. We have an open and entrepreneurial culture, encouraging collaboration internally and externally to make effective therapies. Today, our research benefits from an external network of more than 300 academic and 100 industry alliances focused on areas of mutual scientific interest. We collaborate across scientific and organizational boundaries, with a focus on powerful new technologies that have the potential to help produce therapeutic breakthroughs for patients.